发明授权
EP1404675B1 DPP-IV-INHIBITING PURINE DERIVATIVES FOR THE TREATMENT OF DIABETES
有权
DPP-IV抑制嘌呤衍生物对于糖尿病的治疗
- 专利标题： DPP-IV-INHIBITING PURINE DERIVATIVES FOR THE TREATMENT OF DIABETES
- 专利标题（中）： DPP-IV抑制嘌呤衍生物对于糖尿病的治疗
-
申请号： EP02748629.9申请日： 2002-06-27
-
公开(公告)号： EP1404675B1公开(公告)日： 2008-03-12
- 发明人: KANSTRUP, Anders, Bendtz , SAMS, Christian, Klarner , LUNDBECK, Jane, Marie , CHRISTIANSEN, Lise, Brown , KRISTIANSEN, Marit
- 申请人： NOVO NORDISK A/S
- 申请人地址： Novo Allé 2880 Bagsvaerd DK
- 专利权人： NOVO NORDISK A/S
- 当前专利权人： NOVO NORDISK A/S
- 当前专利权人地址： Novo Allé 2880 Bagsvaerd DK
- 优先权： DK200101049 20010703; DK200200180 20020206
- 国际公布： WO2003004496 20030116
- 主分类号： C07D473/08
- IPC分类号： C07D473/08 ; A61K31/522 ; A61P3/10
摘要：
The present invention relates to therapeutically active and selective inhibitors of the enzyme DPP-IV of formula I, pharmaceutical compositions comprising the compounds and the use of such compounds for and the manufacture of medicaments for treating diseases that are associated with proteins that are subject to inactivation by DPP-IV, such as type 2 diabetes and obesity. (I)
公开/授权文献
信息查询
